STONE STREET GROUPFebruary 2nd, 2022
FiledFebruary 2nd, 2022Chardan Healthcare Acquisition Corp. (NYSE: CHAC, “PHGE”), a special purpose acquisition company (“SPAC”) sponsored by affiliates of Chardan Capital Markets LLC (“Chardan”), and BiomX Ltd. (“BiomX”) entered into a business combination merger agreement on 17 July 2019 to create a publicly listed microbiome company under ticker PHGE focused on developing both natural and engineered phage therapies. The merger was completed on 28 October 2019.